PREVALENCE OF THYROID ABNORMALITIES IN PATIENTS WITH DERMATITIS-HERPETIFORMIS AND IN CONTROL SUBJECTS WITH HLA-B8 HLA-DR3

被引:24
作者
GASPARI, AA
HUANG, CM
DAVEY, RJ
BONDY, C
LAWLEY, TJ
KATZ, SI
机构
[1] NCI,DERMATOL BRANCH,BLDG 10,ROOM 12N238,BETHESDA,MD 20892
[2] WARREN GRANT MAGNUSON CLIN CTR,DEPT CLIN PATHOL,BETHESDA,MD
[3] WARREN GRANT MAGNUSON CLIN CTR,DEPT TRANSFUS MED,BETHESDA,MD
[4] NINCDS,NEUROCHEM LAB,BETHESDA,MD 20205
关键词
D O I
10.1016/0002-9343(90)90464-O
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
purpose: The prevalence of thyroid dysfunction as measured by the presence of overt thyroid disease, abnormal results of thyroid function tests, or antithyroid antibodies was compared in patients with dermatitis herpetiformis (DH) and a normal control group who had the HLA-B8/-DR3 haplotype. patients and methods: The study population consisted of 56 patients with DH and 26 control subjects with the HLA-B8/-DR3 haplotype. All were examined for thyroid function abnormalities and thyroid autoantibodies. results: Patients with DH had a statistically significant increase in the prevalence of abnormal thyroid function test results and autoantibodies: 32% versus 4% for controls (Z = 2.01, p <0.02). In patients with DH, hypothyroidism was the most common thyroid abnormality (12 of 56) followed by hyperthyroidism (four of 56). Two patients had normal thyroid function test results with thyroid autoantibodies. Risk factors for thyroid abnormalities in patients with DH were increasing age (χ2 = 6.55, p <0.02, significant) and the presence of thyroid microsomal antibodies. The HLA-B8/-DR3 haplotype was not a risk factor for thyroid abnormalities. conclusions: The findings suggest that thyroid disease is independently associated with DH. Examination of patients with DH should include thyroid function tests along with assays for antithyroid antibodies. © 1990.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 57 条
[1]   LINKAGE OF HLA-DR-BETA SPECIFIC RESTRICTION FRAGMENT LENGTH POLYMORPHISMS WITH GRAVES-DISEASE [J].
BOEHM, BO ;
SCHIFFERDECKER, E ;
KUEHNL, P ;
SCHOFFLING, K .
ACTA ENDOCRINOLOGICA, 1988, 119 (02) :251-256
[3]  
CALLEN JP, 1979, INT J DERMATOL, V13, P219
[4]   IGA ANTI-ENDOMYSIUM ANTIBODY - A NEW IMMUNOLOGICAL MARKER OF DERMATITIS-HERPETIFORMIS AND CELIAC-DISEASE [J].
CHORZELSKI, TP ;
BEUTNER, EH ;
SULEJ, J ;
TCHORZEWSKA, H ;
JABLONSKA, S ;
KUMAR, V ;
KAPUSCINSKA, A .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (04) :395-402
[5]   NATURAL-HISTORY OF DERMATITIS-HERPETIFORMIS IN SOUTHERN SWEDEN [J].
CHRISTENSEN, OB ;
HINDSEN, M ;
SVENSSON, A .
DERMATOLOGICA, 1986, 173 (06) :271-277
[6]   SUBCLINICAL HYPOTHYROIDISM [J].
COOPER, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (02) :246-247
[7]   DISEASE ASSOCIATIONS - CHANCE, ARTIFACT, OR SUSCEPTIBILITY GENES [J].
COX, NJ ;
BELL, GI .
DIABETES, 1989, 38 (08) :947-950
[8]  
COX NJ, 1949, GENET EPIDEMIOL, V6, P65
[9]   THYROID ABNORMALITIES IN DERMATITIS-HERPETIFORMIS - PREVALENCE OF CLINICAL THYROID-DISEASE AND THYROID AUTOANTIBODIES [J].
CUNNINGHAM, MJ ;
ZONE, JJ .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) :194-196
[10]  
DAVIES MG, 1978, Q J MED, V186, P221